Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intelgenx Technologies Corp IGXT

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

GREY:IGXT - Post Discussion

Intelgenx Technologies Corp > formal agreement with Tilray finalized
View:
Post by Ciao on Nov 07, 2018 8:19am

formal agreement with Tilray finalized

https://www.intelgenx.com/investors/press-releases/press-release-details/2018/IntelGenx-Announces-Definitive-Agreement-with-Tilray-to-Form-an-Exclusive-Worldwide-Partnership-for-Cannabis-Infused-VersaFilm-Products/default.aspx

Small equity interest taken by Tilray and favorable 20/80 development costs.

Comment by Ciao on Nov 07, 2018 1:46pm
muted response compared to intial LOI with Tilray over a month ago, understandably MJ sector and Tilray's share price has cooled off signficantly however, healthy pipeline and clinical studies for Montelukast study are the core of the company which is targeted to be profitable in 2019, investors are mispricing this story stock
Intelgenx Technologies Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities